Twist Bioscience (TWST) Income towards Parent Company (2018 - 2025)
Historic Income towards Parent Company for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to -$30.6 million.
- Twist Bioscience's Income towards Parent Company rose 330.09% to -$30.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$76.6 million, marking a year-over-year increase of 6116.66%. This contributed to the annual value of -$77.7 million for FY2025, which is 6279.57% up from last year.
- According to the latest figures from Q4 2025, Twist Bioscience's Income towards Parent Company is -$30.6 million, which was up 330.09% from -$27.1 million recorded in Q3 2025.
- Over the past 5 years, Twist Bioscience's Income towards Parent Company peaked at $20.4 million during Q2 2025, and registered a low of -$85.6 million during Q2 2024.
- Moreover, its 5-year median value for Income towards Parent Company was -$42.4 million (2022), whereas its average is -$42.9 million.
- Its Income towards Parent Company has fluctuated over the past 5 years, first tumbled by 6946.91% in 2021, then surged by 12381.51% in 2025.
- Quarter analysis of 5 years shows Twist Bioscience's Income towards Parent Company stood at -$45.6 million in 2021, then grew by 8.21% to -$41.8 million in 2022, then dropped by 2.83% to -$43.0 million in 2023, then grew by 26.53% to -$31.6 million in 2024, then increased by 3.3% to -$30.6 million in 2025.
- Its last three reported values are -$30.6 million in Q4 2025, -$27.1 million for Q3 2025, and $20.4 million during Q2 2025.